VIEMED HEALTHCARE, INC. Depreciation
VIEMED HEALTHCARE, INC. (VMD) reported Depreciation of $15.94 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2023-11-01
- VIEMED HEALTHCARE, INC. depreciation for the quarter ending 2023-09-30 was $5.97M, a 44.99% increase year-over-year.
- VIEMED HEALTHCARE, INC. depreciation for the quarter ending 2023-06-30 was $5.21M, a 39.24% increase year-over-year.
- VIEMED HEALTHCARE, INC. depreciation for the quarter ending 2023-03-31 was $4.76M, a 40.18% increase year-over-year.
- VIEMED HEALTHCARE, INC. depreciation for the quarter ending 2022-12-31 was $4.37M, a 40.16% increase year-over-year.
- VIEMED HEALTHCARE, INC. depreciation for fiscal 2022 was $15.63M, a 38.17% increase from fiscal 2021.
- VIEMED HEALTHCARE, INC. depreciation for fiscal 2021 was $11.31M, a 18.05% increase from fiscal 2020.
- VIEMED HEALTHCARE, INC. depreciation for fiscal 2020 was $9.58M, a 49.72% increase from fiscal 2019.
- VIEMED HEALTHCARE, INC. depreciation for fiscal 2019 was $6.40M, a 69.18% increase from fiscal 2018.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2023-09-30 | $5.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $11.18M derived: sum of 2 quarters · filed 2023-11-01 | $15.94M 10-Q · filed 2023-11-01 | $20.32M derived: sum of 4 quarters · filed 2023-11-01 |
| 2023-06-30 | $5.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $9.97M 10-Q · filed 2023-08-09 | $14.34M derived: sum of 3 quarters · filed 2023-08-09 | $18.46M derived: sum of 4 quarters · filed 2023-11-01 |
| 2023-03-31 | $4.76M 10-Q · filed 2023-05-08 | $9.13M derived: sum of 2 quarters · filed 2023-05-08 | $13.26M derived: sum of 3 quarters · filed 2023-11-01 | $17.00M derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-12-31 | $4.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $8.49M derived: sum of 2 quarters · filed 2023-11-01 | $12.23M derived: sum of 3 quarters · filed 2023-11-01 | $15.63M 10-K · filed 2023-03-02 |
| 2022-09-30 | $4.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $7.86M derived: sum of 2 quarters · filed 2023-11-01 | $11.26M 10-Q · filed 2023-11-01 | $14.38M derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $3.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $7.14M 10-Q · filed 2023-08-09 | $10.26M derived: sum of 3 quarters · filed 2023-08-09 | $13.12M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $3.40M 10-Q · filed 2023-05-08 | $6.52M derived: sum of 2 quarters · filed 2023-05-08 | $9.38M derived: sum of 3 quarters · filed 2023-05-08 | $12.10M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $5.99M derived: sum of 2 quarters · filed 2023-03-02 | $8.70M derived: sum of 3 quarters · filed 2023-03-02 | $11.31M 10-K · filed 2023-03-02 |
| 2021-09-30 | $2.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $5.58M derived: sum of 2 quarters · filed 2022-11-01 | $8.19M 10-Q · filed 2022-11-01 | $11.03M derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | $2.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $5.33M 10-Q · filed 2022-08-02 | $8.16M derived: sum of 3 quarters · filed 2022-08-02 | $10.59M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $2.61M 10-Q · filed 2022-05-03 | $5.45M derived: sum of 2 quarters · filed 2022-05-03 | $7.87M derived: sum of 3 quarters · filed 2022-05-03 | $10.06M derived: sum of 4 quarters · filed 2022-05-03 |
| 2020-12-31 | $2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $5.26M derived: sum of 2 quarters · filed 2022-03-07 | $7.45M derived: sum of 3 quarters · filed 2022-03-07 | $9.58M 10-K · filed 2022-03-07 |
| 2020-09-30 | $2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $4.62M derived: sum of 2 quarters · filed 2021-11-02 | $6.75M 10-Q · filed 2021-11-02 | $8.75M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $4.32M 10-Q · filed 2021-08-03 | $6.32M derived: sum of 3 quarters · filed 2021-08-03 | $7.98M derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | $2.13M 10-Q · filed 2021-05-03 | $4.13M derived: sum of 2 quarters · filed 2021-05-03 | $5.79M derived: sum of 3 quarters · filed 2021-05-03 | $7.13M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $3.66M derived: sum of 2 quarters · filed 2021-03-03 | $5.00M derived: sum of 3 quarters · filed 2021-03-03 | $6.40M 10-K · filed 2021-03-03 |
| 2019-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $3.00M derived: sum of 2 quarters · filed 2020-11-04 | $4.40M 10-Q · filed 2020-11-04 | $5.58M derived: sum of 4 quarters · filed 2020-11-04 |
| 2019-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $2.74M 10-Q · filed 2020-08-04 | $3.92M derived: sum of 3 quarters · filed 2020-08-04 | $4.89M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | $1.40M 10-Q · filed 2020-05-05 | $2.58M derived: sum of 2 quarters · filed 2020-05-05 | $3.55M derived: sum of 3 quarters · filed 2020-05-05 | |
| 2018-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $2.15M derived: sum of 2 quarters · filed 2020-03-04 | $3.78M 10-K · filed 2020-03-04 | |
| 2018-09-30 | $972.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $2.61M 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $1.63M 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |